315 related articles for article (PubMed ID: 18779887)
1. Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy.
Fukushima S; Egawa K; Nishi H; Wakasugi S; Ishii N; Hashimoto T; Yancey KB; Ihn H
Acta Derm Venereol; 2008; 88(5):484-7. PubMed ID: 18779887
[TBL] [Abstract][Full Text] [Related]
2. Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations.
Egan CA; Lazarova Z; Darling TN; Yee C; Yancey KB
Medicine (Baltimore); 2003 May; 82(3):177-86. PubMed ID: 12792304
[TBL] [Abstract][Full Text] [Related]
3. A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer.
Sadler E; Lazarova Z; Sarasombath P; Yancey KB
J Dermatol Sci; 2007 Jul; 47(1):1-7. PubMed ID: 17467241
[TBL] [Abstract][Full Text] [Related]
4. IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit.
Lazarova Z; Yee C; Lazar J; Yancey KB
Clin Immunol; 2001 Oct; 101(1):100-5. PubMed ID: 11580232
[TBL] [Abstract][Full Text] [Related]
5. Mucous membrane pemphigoid with antibodies against β3 subunit of laminin-332: first report from India.
Kanwar AJ; Vinay K; Koga H; Hashimoto T
Indian J Dermatol Venereol Leprol; 2012; 78(4):475-9. PubMed ID: 22772619
[TBL] [Abstract][Full Text] [Related]
6. Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita.
Fujimoto W; Ishida-Yamamoto A; Hsu R; Nagao Y; Iizuka H; Yancey KB; Arata J
Br J Dermatol; 1998 Oct; 139(4):682-7. PubMed ID: 10025973
[TBL] [Abstract][Full Text] [Related]
7. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease.
Egan CA; Yancey KB
Eur J Dermatol; 2000 Dec; 10(8):585-9. PubMed ID: 11125317
[TBL] [Abstract][Full Text] [Related]
8. Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the beta and gamma subunits of laminin 5.
Fujimoto W; Toi Y; Okazaki F; Lazarova Z; Yancey KB; Arata J
J Am Acad Dermatol; 1999 Apr; 40(4):637-9. PubMed ID: 10188690
[TBL] [Abstract][Full Text] [Related]
9. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder.
Domloge-Hultsch N; Anhalt GJ; Gammon WR; Lazarova Z; Briggaman R; Welch M; Jabs DA; Huff C; Yancey KB
Arch Dermatol; 1994 Dec; 130(12):1521-9. PubMed ID: 7986125
[TBL] [Abstract][Full Text] [Related]
10. [Cicatricial pemphigoid with autoantibodies to laminin 5 (epiligrin) in a patient with metastatic endometrial carcinoma].
Lenz P; Hsu R; Yee C; Yancey K; Volc-Platzer B; Stingl G; Kirnbauer R
Hautarzt; 1998 Jan; 49(1):31-5. PubMed ID: 9522190
[TBL] [Abstract][Full Text] [Related]
11. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
[TBL] [Abstract][Full Text] [Related]
12. Anti-epiligrin (laminin 5) cicatricial pemphigoid and lung carcinoma: coincidence or association?
Gibson GE; Daoud MS; Pittelkow MR
Br J Dermatol; 1997 Nov; 137(5):780-2. PubMed ID: 9415241
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid.
Lazarova Z; Sitaru C; Zillikens D; Yancey KB
J Am Acad Dermatol; 2004 Dec; 51(6):886-92. PubMed ID: 15583578
[TBL] [Abstract][Full Text] [Related]
14. Ocular involvement in anti-epiligrin cicatricial pemphigoid.
Nischler C; Sadler E; Lazarova Z; Stoiber J; Ruckhofer J; Pohla-Gubo G; Emberger M; Bauer JW; Grabner G; Hintner H
Eur J Ophthalmol; 2006; 16(6):867-9. PubMed ID: 17191196
[TBL] [Abstract][Full Text] [Related]
15. [Anti-laminin 5 mucous membrane pemphigoid].
Benoit S; Schmidt E; Sitaru C; Rose C; Goebeler M; Bröcker EB; Zillikens D
J Dtsch Dermatol Ges; 2006 Jan; 4(1):41-4. PubMed ID: 16503930
[TBL] [Abstract][Full Text] [Related]
16. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of anti-laminin 5 mucous membrane pemphigoid.
Rose C; Schmidt E; Kerstan A; Thoma-Uszynski S; Wesselmann U; Käsbohrer U; Zillikens D; Shimanovich I
J Am Acad Dermatol; 2009 Sep; 61(3):433-40. PubMed ID: 19700013
[TBL] [Abstract][Full Text] [Related]
18. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit.
Letko E; Gürcan HM; Papaliodis GN; Christen W; Foster CS; Ahmed AR
Clin Exp Dermatol; 2007 Nov; 32(6):637-41. PubMed ID: 17524068
[TBL] [Abstract][Full Text] [Related]
19. Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?
Leverkus M; Schmidt E; Lazarova Z; Bröcker EB; Yancey KB; Zillikens D
Arch Dermatol; 1999 Sep; 135(9):1091-8. PubMed ID: 10490114
[TBL] [Abstract][Full Text] [Related]
20. Anti-laminin-332 mucous membrane pemphigoid associated with recurrent metastatic prostate carcinoma: hypothesis for a paraneoplastic phenomenon.
Young AL; Bailey EE; Colaço SM; Engler DE; Grossman ME
Eur J Dermatol; 2011; 21(3):401-4. PubMed ID: 21527374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
